You just read:

Neurotrope Presents Phase 2 Data Assessing Bryostatin-1 in Moderate-to-Severe Alzheimer's Patients at AAIC 2017

News provided by

Neurotrope, Inc.

19 Jul, 2017, 16:36 BST